TRACON Pharmaceuticals Inc (TCON)
1.88
+0.02
(+0.97%)
USD |
NASDAQ |
Apr 24, 16:00
1.88
0.00 (0.00%)
After-Hours: 20:00
TRACON Pharmaceuticals Research and Development Expense (Quarterly): 1.494M for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 1.494M |
September 30, 2023 | 2.326M |
June 30, 2023 | 3.488M |
March 31, 2023 | 4.969M |
December 31, 2022 | 3.875M |
September 30, 2022 | 4.097M |
June 30, 2022 | 2.923M |
March 31, 2022 | 2.993M |
December 31, 2021 | 3.064M |
September 30, 2021 | 2.73M |
June 30, 2021 | 3.068M |
March 31, 2021 | 2.284M |
December 31, 2020 | 2.197M |
September 30, 2020 | 1.785M |
June 30, 2020 | 2.218M |
March 31, 2020 | 1.998M |
December 31, 2019 | 1.913M |
September 30, 2019 | 3.056M |
June 30, 2019 | 4.347M |
March 31, 2019 | 5.214M |
December 31, 2018 | 5.931M |
Date | Value |
---|---|
September 30, 2018 | 6.976M |
June 30, 2018 | 8.115M |
March 31, 2018 | 9.438M |
December 31, 2017 | 4.623M |
September 30, 2017 | 4.257M |
June 30, 2017 | 4.893M |
March 31, 2017 | 5.582M |
December 31, 2016 | 4.767M |
September 30, 2016 | 4.531M |
June 30, 2016 | 6.773M |
March 31, 2016 | 5.495M |
December 31, 2015 | 10.56M |
September 30, 2015 | 5.885M |
June 30, 2015 | 5.405M |
March 31, 2015 | 3.831M |
December 31, 2014 | 2.562M |
September 30, 2014 | 2.269M |
June 30, 2014 | 1.56M |
March 31, 2014 | 1.261M |
December 31, 2013 | 1.76M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
1.494M
Minimum
Dec 2023
4.969M
Maximum
Mar 2023
2.886M
Average
2.923M
Median
Jun 2022
Research and Development Expense (Quarterly) Benchmarks
BioSig Technologies Inc | 1.176M |
Revolution Medicines Inc | 148.48M |
Perspective Therapeutics Inc | 6.08M |
Electromed Inc | 0.107M |
Xtant Medical Holdings Inc | 0.492M |